A 42-year-old female presented to us with a complaint of sudden painless loss of vision in both eyes of three days duration. Visual acuity was 20/100 for distance in both eyes.
Majji Ajit, Bhatia Kapil, Mathai Annie
doaj
Púrpura Trombocitopénica Idiopática Infantil. Cuidados Integrales
Púrpura trombocitopénica idiopática o PTI es el trastorno hemorrágico autoinmunitario más frecuente en niños/as. A partir del Proceso de Atención de Enfermería, el personal de enfermería desde una perspectiva holística llevará a cabo los cuidados al niño/
Carmen Tamara González Fernández
doaj
Long-term use of anti-D in chronic idiopathic thrombocytopenic purpura
Chronic idiopathic thrombocytopenic purpura is an autoimmune disease characterized by antibody-mediated destruction of platelets. To maintain the platelets above the symptomatic level, we administered anti-D (100 micrograms for 5 consecutive days)
I Yaprak +5 more
doaj
Loo Wan-Wei,1,2 Tuan-Jaffar Tengku-Norina,1 Ahmad-Alwi Azma-Azalina,1 Abdul-Ghani Zulkifli,1 Embong Zunaina21Department of Ophthalmology, Hospital Raja Perempuan Zainab II, Kota Bharu, 2Department of Ophthalmology, School of Medical Sciences, Health ...
Wan-Wei L +4 more
doaj
Warm Autoimmune Hemolytic Anemia in an Elderly Patient With a History of Chronic Idiopathic Thrombocytopenic Purpura: A Case Report. [PDF]
Pitaro AT +4 more
europepmc +1 more source
Clinical presentation and treatment outcomes in a South African thrombotic thrombocytopenic purpura cohort with and without HIV. [PDF]
Vundla N +4 more
europepmc +1 more source
Bilateral Peripheral Facial Nerve Palsy: A Rare Clinical Picture. [PDF]
Geisselmaier T +6 more
europepmc +1 more source
Acquired Thrombotic Thrombocytopenic Purpura with a Poor Response to Treatment can be an Initial Manifestation of Occult Signet Ring Cell Carcinoma and other Malignancies. [PDF]
Ahmad M +4 more
europepmc +1 more source
ITP, easy as EBV: a rare case of severe immune thrombocytopenic purpura secondary to Epstein-Barr virus. [PDF]
Hanna CS +4 more
europepmc +1 more source
Four-year complete remission with reduced-dose PARP inhibitor in advanced-stage epithelial ovarian cancer harboring a BRCA1 mutation: a case report of a chemotherapy-intolerant patient with idiopathic thrombocytopenic purpura. [PDF]
Lu P +5 more
europepmc +1 more source

